New ingredient by NXT USA to support women’s health will be launched at Expo West 2025

Image | adobe.stock/Jade Maas/peopleimages.com

In a February 25, 2025, press release, health ingredient provider NXT USA announced the launch of Xeya Shatavari 15% at Natural Products Expo West, taking place March 4-7 in Anaheim, California. The new ingredient is intended to support women’s hormonal health at various stages in life.

“Xeya represents what truly sets our company apart—efficacy and scientific validation,” said Eric Anderson, managing director, NXT USA, in the press release. “We are committed to offering a targeted women’s supplement that is not only rooted in centuries of traditional wisdom, but also backed by clinical research.”

Xeya is rooted in Ayurvedic tradition and contains standardized Shatavari extract (15% Shatavarins), an adaptogenic herb used in Ayurvedic medicine to support vitality and promote stress resilience. Xeya has been clinically validated at 100mg per day in two human studies, pending publication, and is intended to promote hormonal balance, support menstrual health, and ease symptoms of polycystic ovary syndrome (PCOS), perimenopause, and menopause.

“For too long, women’s health has been underserved and overlooked in scientific research,” Anderson added. “Xeya, designed for health-conscious women aged 18 to 75+, helps fill this gap by supporting hormonal fluctuations across life’s key transitions—from menstrual health to perimenopause and beyond. In today’s fast-paced world, women face unique physiological demands, and Shatavari’s adaptogenic properties can offer critical support for stress management, cognition, and overall well-being.”

NXT USA will be at booth #3576 at Expo West.